High Prevalence of Brain Tumor and R&D of New Drugs to Augment Growth of Anaplastic Ast... - 0 views
-
ajinkyak on 30 Jul 21High prevalence of brain tumor is expected to propel growth of the anaplastic astrocytoma treatment market. For instance, according to The Central Brain Tumor Registry of the United States (2020 CBTRUS Statistical Report), the incidence rate of all primary malignant and non-malignant brain and other central nervous system tumors in the U.S was 23.79 cases per 100,000 for a total count of 415,411 incident tumors.